Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1000
-0.0050 (-4.76%)
Jan 20, 2026, 3:11 PM EST
Pharmala Biotech Holdings Company Description
Pharmala Biotech Holdings Inc., a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.
Pharmala Biotech Holdings Inc.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Nicholas Kadysh |
Contact Details
Address: 1055 West Georgia Street Vancouver, BC V6E 4N7 Canada | |
| Website | pharmala.ca |
Stock Details
| Ticker Symbol | MDMA |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | September - August |
| Reporting Currency | CAD |
| ISIN Number | CA71719L1067 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Nicholas Kadysh | Director, President and Chief Executive Officer |
| Harpreet Kaur | Vice President of Research |
| Dr. Farnoud Kazemzadeh | Chief Operating Officer |
| Ali Taghva | Chief Commercial Officer |